Manu Jain, MD
Enriched profileProfessor, Medicine (Pulmonary and Critical Care) and Pediatrics; Director, Adult Cystic Fibrosis Program; Co-center Director, Cystic Fibrosis (Lurie Children's Hospital and Northwestern Medicine) · Northwestern University Feinberg School of Medicine
Manu Jain is Professor, Medicine (Pulmonary and Critical Care) and Pediatrics; Director, Adult Cystic Fibrosis Program; Co-center Director, Cystic Fibrosis (Lurie Children's Hospital and Northwestern Medicine) at Northwestern University Feinberg School of Medicine. OpenAlex indexes 208 publications with 12,177 citations (h-index 45); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Pulmonary Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Manu Jain, MD, is Professor, Medicine (Pulmonary and Critical Care) and Pediatrics at Northwestern University Feinberg School of Medicine (Northwestern Memorial Hospital / Northwestern Medicine). The public record shows 208 publications with 12,177 citations (h-index 45), centered on Respiratory. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 10 companies, 4 NIH-funded awards (2000–2024).
- Most recent indexed publication: 2025 · Proceedings of the National Academy of Sciences of the United States of America
- Top research focus: Respiratory
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 10 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 9 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Health Outcomes of Parents With Cystic Fibrosis-Aim 2
Sponsor: University of Pittsburgh
- A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions
Sponsor: Memorial Sloan Kettering Cancer Center
- Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis
Sponsor: Northwestern University
Industry payments
Updated 27 Aug 2026
10 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20256 payments
- Insmed, Inc.Program year202512 payments
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20242 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
48.4%Corticosteroid29.8%Trelegy Ellipta44%Breo Ellipta33%Budesonide-Formoterol Fumarate23%Part D<11 patientsbeta2-Adrenergic Agonist18.6%Albuterol Sulfate Hfa100%Part D≥15 patientsAnti-infectives
41.6%Macrolide Antimicrobial41.6%Azithromycin100%Part D≥13 patientsMetabolism & gastrointestinal
9.9%Proton pump inhibitor9.9%Omeprazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
4 NIH research awards on record, funded 2000–2024 per NIH RePORTER. The latest:
- 7th Annual Workshop on Confocal Microscopy for Cutaneous Diagnostics
Sloan-Kettering Inst Can Research
FY2024$8,000R13CA294694 - Mitochondrial metabolism as a therapeutic target in pulmonary fibrosis
Jesse Brown Va Medical Center
FY2024I01CX001777 - Assessing the role of metabolism in monocyte to macrophage differentiation in pulmonary fibrosis
Jesse Brown Va Medical Center
FY2022I01CX001777
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Remote analysis and management of sweat biomarkers using a wearable microfluidic sticker in adult cystic fibrosis patients.
Proceedings of the National Academy of Sciences of the United States of America
Article2025 - Pulmonary Fibrosis and Antioxidants: Finding the Right Target.
American journal of respiratory cell and molecular biology
Comment2023 - Expression of ACE2-a Key SARS-CoV-2 Entry Factor-Is Not Increased in the Nasal Mucosa of People with Cystic Fibrosis.
American journal of respiratory cell and molecular biology
Letter2022 - A Call for Rational Intensive Care in the Era of COVID-19.
American journal of respiratory cell and molecular biology
Letter2020
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/manu-jain-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- X / Twitter
x.com/NM_Lung/status/1958594504631497041
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Board Certified
American Board of Internal Medicine - Pulmonary Disease
- Board Certified
American Board of Internal Medicine - Critical Care Medicine
Editorial & leadership roles
journal and society appointments- Site Co-Principal Investigator
Cystic Fibrosis Foundation Therapeutic Development Network (TDN) center at Northwestern
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →scholars.northwestern.edu ↗ - Member
Cystic Fibrosis Foundation Center Committee
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →scholars.northwestern.edu ↗
Secondary affiliations
appointments beyond the home institution- Department of Pediatrics
Northwestern University Feinberg School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →feinberg.northwestern.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.northwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →feinberg.northwestern.edu ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
- "Focus on Cystic Fibrosis" transcript/panel discussion (Simpson Querrey Lung Institute for Translational Science) covering CF clinical care
outcomes, pregnancy/parenting with CF, and clinical trials
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →feinberg.northwestern.edu ↗ - Listed as a Northwestern faculty media expert available to journalists on topics including drug development
genetic medicine, pneumonia, precision medicine, and pulmonary disease
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.northwestern.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Martin Tallman, MD
Northwestern University Feinberg School of Medicine
Al Benson, MD
Northwestern University Feinberg School of Medicine
Sanjiv Shah, MD
Northwestern University Feinberg School of Medicine
Sadiya Khan, MD
Northwestern University Feinberg School of Medicine